Mirae Asset Global Etfs Holdings Ltd. Foghorn Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,864 shares of FHTX stock, worth $104,257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,864
Previous 9,762
42.02%
Holding current value
$104,257
Previous $56,000
130.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FHTX
# of Institutions
80Shares Held
33.3MCall Options Held
8.7KPut Options Held
2.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$95.3 Million20.03% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$39.9 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$22.8 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$17.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$13 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $313M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...